Search Browse Earnings

Genprex, Inc. — SlamSEC

Genprex, Inc.

Nasdaq:GNPX

Pharmaceutical Preparations·AUSTIN, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

-$31.0M

FY 2024

Net Income

-$30.9M

FY 2024

EPS (Diluted)

-$22.56

FY 2024

Stock Price

$2.00

+0.0%

2026-03-11

52W Range

$1.71 – $55.00

P/E Ratio

-0.1x

Market Cap

$4.5M

Cash

$6.7M

FY 2024

Total Debt

—

Net Cash

$6.7M

FY 2024

Enterprise Value

-$2.2M

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

0.1x

Employees

—

CEO

Confer Ryan M.